Erratum: Adipocyte glucocorticoid receptor deficiency attenuates aging-and HFD-induced obesity and impairs the feeding-fasting transition (Diabetes (2017) 66 (272–286) DOI: 10.2337/db16-0381);Adipocyte glucocorticoid receptor deficiency attenuates aging- and HFD-induced obesity and impairs the feeding-fasting transition

Diabetes

Volumn 66, Issue 2, 2017, Pages 272-286

  Mueller, Kristina M ^a,b   Hartmann, Kerstin ^c   Kaltenecker, Doris ^b   Vettorazzi, Sabine ^c   Bauer, Mandy ^c   Mauser, Lea ^c   Amann, Sabine ^d   Jall, Sigrid ^e,f   Fischer, Katrin ^e,f   Esterbauer, Harald ^d   Müller, Timo D ^e,f   Tschöp, Matthias H ^e,f   Magnes, Christoph ^g   Haybaeck, Johannes ^h   Scherer, Thomas ^d   Bordag, Natalie ⁱ   Tuckermann, Jan P ^c   Moriggl, Richard ^a,b,d  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF ULM   (Germany)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g JOANNEUM RESEARCH   (Austria)

^h MEDICAL UNIVERSITY OF GRAZ   (Austria)

ⁱ CBmed Center for Biomarker Research in Medicine   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COA CARBOXYLASE; ADENYLATE CYCLASE; ADIPONECTIN; ALPHA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA KETONE; BIOLOGICAL MARKER; CD36 ANTIGEN; CHOLESTEROL; CORTICOSTERONE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIACYLGLYCEROL ACYLTRANSFERASE 2; FATTY ACID; FATTY ACID BINDING PROTEIN 4; FATTY ACID SYNTHASE; FATTY ACID TRANSPORTER 4; FIBROBLAST GROWTH FACTOR 21; GLUCOCORTICOID RECEPTOR; GLUCOSE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE 3; INSULIN; KETONE; LEPTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROTEIN KINASE B; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1;

ADIPOCYTE; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DIET INDUCED OBESITY; DIET RESTRICTION; EPIDIDYMIS FAT; FAT MASS; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY LIVER; GENE INACTIVATION; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LIPID DIET; LIPID METABOLISM; LIPOLYSIS; LOCOMOTION; MALE; METABOLIC DISORDER; METABOLIC REGULATION; METABOLOMICS; MOUSE; NONHUMAN; NUCLEOTIDE METABOLISM; OXIDATIVE PHOSPHORYLATION UNCOUPLING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THERMOGENESIS; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WASTING SYNDROME; WHITE ADIPOSE TISSUE; ADIPOSE TISSUE; ANIMAL; ENERGY METABOLISM; FEEDING BEHAVIOR; GENETICS; HYPERTROPHY; LIQUID CHROMATOGRAPHY; LIVER; MASS SPECTROMETRY; METABOLISM; OBESITY; WESTERN BLOTTING;

ADENYLYL CYCLASES; ADIPOCYTES; ADIPOSE TISSUE; ADIPOSITY; AGING; ANIMALS; BLOTTING, WESTERN; CHROMATOGRAPHY, LIQUID; DIET, HIGH-FAT; ENERGY METABOLISM; FASTING; FATTY LIVER; FEEDING BEHAVIOR; HYPERTROPHY; INSULIN; LIPID METABOLISM; LIPOLYSIS; LIVER; MASS SPECTROMETRY; METABOLOMICS; MICE; OBESITY; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION;

EID: 85011634531     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db18-er02a     Document Type: Erratum

References (53)

1. Rose AJ, Herzig S. Metabolic control through glucocorticoid hormones: an update. Mol Cell Endocrinol 2013;380:65-78
2. Geer EB, Islam J, Buettner C. Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism. Endocrinol Metab Clin North Am 2014;43:75-102
3. Shimizu N, Maruyama T, Yoshikawa N, et al. A muscle-liver-fat signalling axis is essential for central control of adaptive adipose remodelling. Nat Commun 2015;6:6693
4. Okun JG, Conway S, Schmidt KV, et al. Molecular regulation of urea cycle function by the liver glucocorticoid receptor. Mol Metab 2015;4:732-740
5. Rosen ED, Spiegelman BM. What we talk about when we talk about fat. Cell 2014;156:20-44
6. Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest 2016;126:12-22
7. Xu C, He J, Jiang H, et al. Direct effect of glucocorticoids on lipolysis in adipocytes. Mol Endocrinol 2009;23:1161-1170
8. Gray NE, Lam LN, Yang K, Zhou AY, Koliwad S, Wang JC. Angiopoietin-like 4 (Angptl4) protein is a physiological mediator of intracellular lipolysis in murine adipocytes. J Biol Chem 2012;287:8444-8456
9. Yu CY, Mayba O, Lee JV, et al. Genome-wide analysis of glucocorticoid receptor binding regions in adipocytes reveal gene network involved in triglyceride homeostasis. PLoS One 2010;5:e15188
10. Gathercole LL, Morgan SA, Bujalska IJ, Hauton D, Stewart PM, Tomlinson JW. Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue. PLoS One 2011;6:e26223
11. Chimin P, Farias TdaS, Torres-Leal FL, et al. Chronic glucocorticoid treatment enhances lipogenic activity in visceral adipocytes of male Wistar rats. Acta Physiol (Oxf) 2014;211:409-420
12. Lee MJ, Fried SK, Mundt SS, et al. Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue. Obesity (Silver Spring) 2008;16:1178-1185
13. Engeli S, Böhnke J, Feldpausch M, et al. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res 2004;12:9-17
14. Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166-2170
15. Morton NM, Paterson JM, Masuzaki H, et al. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 2004;53:931-938
16. Kershaw EE, Morton NM, Dhillon H, Ramage L, Seckl JR, Flier JS. Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity. Diabetes 2005;54:1023-1031
17. Tronche F, Kellendonk C, Kretz O, et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 1999; 23:99-103
18. Eguchi J, Wang X, Yu S, et al. Transcriptional control of adipose lipid handling by IRF4. Cell Metab 2011;13:249-259
19. Müller TD, Müller A, Yi CX, et al. The orphan receptor Gpr83 regulates systemic energy metabolism via ghrelin-dependent and ghrelin-independent mechanisms. Nat Commun 2013;4:1968
20. Schweiger M, Eichmann TO, Taschler U, Zimmermann R, Zechner R, Lass A. Measurement of lipolysis. Methods Enzymol 2014;538:171-193
21. Engblom D, Kornfeld JW, Schwake L, et al. Direct glucocorticoid receptor-Stat5 interaction in hepatocytes controls body size and maturation-related gene expression. Genes Dev 2007;21:1157-1162
22. Bajad SU, Lu W, Kimball EH, Yuan J, Peterson C, Rabinowitz JD. Separation and quantitation of water soluble cellular metabolites by hydrophilic interaction chromatography-tandem mass spectrometry. J Chromatogr A 2006;1125:76-88
23. Fröhlich EE, Farzi A, Mayerhofer R, et al. Cognitive impairment by antibioticinduced gut dysbiosis: analysis of gut microbiota-brain communication. Brain Behav Immun 2016;56:140-155
24. Yuan M, Breitkopf SB, Yang X, Asara JM. A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc 2012;7:872-881
25. Sumner LW, Amberg A, Barrett D, et al. Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 2007;3:211-221
26. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria 2014. Available from http://www.R-project.org/. Accessed 2 July 2015
27. Tschöp MH, Speakman JR, Arch JR, et al. A guide to analysis of mouse energy metabolism. Nat Methods 2011;9:57-63
28. Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011;17:448-453
29. Satapati S, Sunny NE, Kucejova B, et al. Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver. J Lipid Res 2012;53:1080-1092
30. Rebrin K, Steil GM, Getty L, Bergman RN. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 1995;44:1038-1045
31. Wu Q, Kazantzis M, Doege H, et al. Fatty acid transport protein 1 is required for nonshivering thermogenesis in brown adipose tissue. Diabetes 2006;55:3229-3237
32. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 2007;5:426-437
33. Zechner R, Zimmermann R, Eichmann TO, et al. FAT SIGNALS-lipases and lipolysis in lipid metabolism and signaling. Cell Metab 2012;15:279-291
34. Li YQ, Shrestha YB, Chen M, Chanturiya T, Gavrilova O, Weinstein LS. Gsa deficiency in adipose tissue improves glucose metabolism and insulin sensitivity without an effect on body weight. Proc Natl Acad Sci USA 2016;113:446-451
35. Schreiber R, Hofer P, Taschler U, et al. Hypophagia and metabolic adaptations in mice with defective ATGL-mediated lipolysis cause resistance to HFDinduced obesity. Proc Natl Acad Sci USA 2015;112:13850-13855
36. Perry RJ, Zhang XM, Zhang D, et al. Leptin reverses diabetes by suppression of the hypothalamic-pituitary-Adrenal axis. Nat Med 2014;20:759-763
37. Kumashiro N, Beddow SA, Vatner DF, et al. Targeting pyruvate carboxylase reduces gluconeogenesis and adiposity and improves insulin resistance. Diabetes 2013;62:2183-2194
38. Morgan SA, McCabe EL, Gathercole LL, et al. 11b-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess. Proc Natl Acad Sci USA 2014;111:E2482-E2491
39. Lacasa D, Agli B, Giudicelli Y. Permissive action of glucocorticoids on catecholamine-induced lipolysis: direct "in vitro" effects on the fat cell betaadrenoreceptor-coupled-Adenylate cyclase system. Biochem Biophys Res Commun 1988;153:489-497
40. Bartness TJ, Shrestha YB, Vaughan CH, Schwartz GJ, Song CK. Sensory and sympathetic nervous system control of white adipose tissue lipolysis. Mol Cell Endocrinol 2010;318:34-43
41. Scherer T, O'Hare J, Diggs-Andrews K, et al. Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab 2011;13:183-194
42. Saito N, Guitart X, Hayward M, Tallman JF, Duman RS, Nestler EJ. Corticosterone differentially regulates the expression of Gs alpha and Gi alpha messenger RNA and protein in rat cerebral cortex. Proc Natl Acad Sci USA 1989;86:3906-3910
43. Lim HW, Uhlenhaut NH, Rauch A, et al. Genomic redistribution of GR monomers and dimers mediates transcriptional response to exogenous glucocorticoid in vivo. Genome Res 2015;25:836-844
44. Mottillo EP, Balasubramanian P, Lee YH, Weng C, Kershaw EE, Granneman JG. Coupling of lipolysis and de novo lipogenesis in brown, beige, and white adipose tissues during chronic b3-Adrenergic receptor activation. J Lipid Res 2014;55:2276-2286
45. Goossens GH. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav 2008;94:206-218
46. Morán-Salvador E, López-Parra M, García-Alonso V, et al. Role for PPARg in obesity-induced hepatic steatosis as determined by hepatocyte-And macrophagespecific conditional knockouts. FASEB J 2011;25:2538-2550
47. Koonen DP, Jacobs RL, Febbraio M, et al. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes 2007;56:2863-2871
48. Wilson CG, Tran JL, Erion DM, Vera NB, Febbraio M, Weiss EJ. Hepatocytespecific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice. Endocrinology 2016;157:570-585
49. Wu JW, Wang SP, Casavant S, Moreau A, Yang GS, Mitchell GA. Fasting energy homeostasis in mice with adipose deficiency of desnutrin/adipose triglyceride lipase. Endocrinology 2012;153:2198-2207
50. Heckmann BL, Zhang X, Xie X, et al. Defective adipose lipolysis and altered global energy metabolism in mice with adipose overexpression of the lipolytic inhibitor G0/G1 switch gene 2 (G0S2). J Biol Chem 2014;289: 1905-1916
51. Jaeger D, Schoiswohl G, Hofer P, et al. Fasting-induced G0/G1 switch gene 2 and FGF21 expression in the liver are under regulation of adipose tissue derived fatty acids. J Hepatol 2015;63:437-445
52. Liang Q, Zhong L, Zhang J, et al. FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting. Diabetes 2014;63:4064-4075
53. Bordag N, Klie S, Jürchott K, et al. Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects. Sci Rep 2015;5:15954